Amyotrophic Lateral Sclerosis (ALS) Efficacy Studies Form

De-risk your ALS program early. The JAX in vivo ALS preclinical team brings unmatched expertise in model disease progression across key ALS models – including SOD1-G93A, C9orf72, and TDP-43 – and in executing translational, IND-supporting assays.

Fill out the form below, and a team member will contact you shortly to discuss your study design and program needs.